Electromedical Technologies, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Electromedical Technologies, Inc. (EMED) manufactures and markets FDA-cleared bioelectronics therapy devices for non-invasive pain management targeting chronic and acute conditions including arthritis, back pain, and inflammation; its core products comprise the WellnessPro Plus, a prescription transcutaneous electrical nerve stimulation (TENS) device featuring proprietary DeepPulse pre-modulation technology for deeper tissue penetration; the WellnessPro POD, a compact clinical-grade wearable unit for on-the-go therapy; and the Wellness ION Pen, an interferential cold laser pen delivering targeted frequency stimulation to enhance circulation, promote tissue healing, and reduce pain. Founded in 2002 and headquartered at 16561 N 92nd Street, Suite 101, Scottsdale, Arizona, the company operates primarily in the United States with distribution through healthcare professionals, clinics, and direct-to-consumer channels, employing six people as of the latest reports. Recent developments include a strategic partnership with Lionheart Health in 2024 to integrate EMED devices into over 124 locations for medical aesthetics and longevity markets; the unveiling of advanced specifications for the WellnessPro Infinity next-generation device in late 2024, incorporating signal amplifiers, power management systems, and user interface modules with production ramp-up planned for early 2025; and mid-2025 updates highlighting financial restructuring, new board appointments, regulatory alignment, and expanded distribution agreements.
Electromedical Technologies, Inc. (OTC: EMED) Provides Mid-Year Update Highlighting Financial Restructuring, Regulatory Alignment, and Strategic Progress
Electromedical Technologies Unveils Groundbreaking Details About the WellnessPro Infinity and Announces Production Timeline
Electromedical Provides Update to Shareholders
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement.
Electromedical Technologies Receives Key Medical Device Certification
Electromedical Technologies Clarifies Comparative Six-Month Highlights Reported in August 18, 2021 Press Release
Electromedical Technologies Reports Comparative 48% Revenue Growth for June 2021 Quarter
Electromedical Technologies and Nazarbayev University to Commence Landmark Alzheimer's Disease Research Program
Electromedical Technologies Flagship Device to Be Introduced at National Chiropractic Expo
Electromedical Technologies and Nazarbayev University Complete Agreement to Expand Promising Joint Research Programs
Electromedical Technologies' New Weekly Marketing Series Launches This Week
Electromedical Technologies Announces Upcoming Facebook Live Event with Noted Chiropractor
Electromedical Technologies Enters Phase 2 of Prototype development on WellnessPro POD™
Electromedical Technologies, Inc. Featured on The Big Biz Radio Show
Electromedical Technologies, Inc. Issues Statement on Recently Identified Promotional Activity Concerning its Common Stock